Exploratory subgroup analyses suggested a possible trend toward greater antiproteinuric response in patients with higher baseline proteinuria or moderate renal impairment; however, no statistically significant interaction was observed, and these findings should be interpreted with caution.
← all excerpts
Dapagliflozin in lupus nephritis: renal and hematologic outcomes from a randomized controlled trial.
1
—
—